FREQUENTLY ASKED QUESTIONS Tirzepatide is an advanced oral medication that promotes significant weight loss by suppressing appetite, regulating blood sugar, and improving metabolic function
At Hormonally Balanced, clinicians evaluate medical history, hormones, and metabolic health before prescribing GLP-1 therapy, supporting safe appetite regulation and long-term weight management
(2018) reported that GLP-1 induces either an increase or a decrease of spontaneous firing rate in GLP-1R expressing BNST neurons
Advanced Body Composition Analysis Utilizing cutting-edge 3D scanning and impedance technology for accurate and detailed progress tracking
Weight loss and warfarin dosing Warfarin dosing is influenced by body weight in several ways
Product Tirzepatide Stated quantity 10 mg Batch number SN-TIRZ-B2601 Supplier COA content result 11.23 mg Supplier COA manufacture date 16 March 2026 Supplier COA report date 27 March 2026 Supplier COA expiry date 15 March 2028 Documentation status Supplier certificate of analysis available Intended use Laboratory research only Previews are redacted, watermarked public copies